Call us: 0800 720 721 or e-mail: info@actionfortransparency.org

Kenya’s Drug-Resistant Tuberculosis Burden

Iqra Salah, A4T grantee, has been investigating Kenya’s growing burden of drug resistant Tuberculosis. DR-TB is exerting a significant strain on the country’s economy and the health of the patients. It is six times more expensive to treat the disease per episode than it is drug-sensitive Tuberculosis, notwithstanding the severe side effects.

See the video below of Africa Uncensored’s Iqra Salah as she spoke to one of the patients whose condition is worsening as he can’t afford medication despite being covered by the National Health Insurance Fund (NHIF).

Leave a reply